11:34 AM · 7 July 2020

BREAKING: Novavax announces $1.6B funding, +44% in pre-market!

Novavax Inc (NVAX.US) officially announced $1.6 billion funding from Operation Warp Speed. The company has been selected to participate in Operation Warp Speed (OWS) - U.S. government program which goal is to deliver millions of doses of vaccine for COVID-19 in 2021. Funding should support late-stage clinical development and establishing large-scale manufacturing. As a result, the company is supposed to deliver 100 million doses of NVX-Cov2373 - Novavax’ COVID-19 vaccine candidate. Production ought to start in late 2020. 

Novavax Inc (NVAX.US) share price is surging in the pre-market trading following a promising announcement. The company has already benefited from the coronavirus pandemic as it has been engaged in some clinical development of its coronavirus vaccine. As one can notice on the chart above, stock did open with a huge bullish gaps in the past and it should also be the case today. Source: xStation5

22 May 2026, 11:46 AM

Market Wrap: Technology Stocks Keep European Markets Afloat💡

21 May 2026, 6:19 PM

Walmart falls despite strong earnings

21 May 2026, 5:18 PM

Oil keeps rising: is there reason to worry?

21 May 2026, 4:35 PM

The US Government Supports the Quantum Revolution

The financial instruments we offer, especially CFDs, can be highly risky. Fractional Shares (FS) is an acquired from XTB fiduciary right to fractional parts of stocks and ETFs. FS are not a separate financial instrument. The limited corporate rights are associated with FS.
This page was not created for investors residing in Brazil. This brokerage is not authorized by the Comissão de Valores Mobiliários (CVM) or the Brazilian Central Bank (BCB). The content of this page should not be characterized as an investment offer in Brazil or for investors residing in that country.
Losses can exceed deposits